Information Provided By:
Fly News Breaks for May 18, 2015
RHHBY
May 18, 2015 | 09:23 EDT
UBS upgraded Roche to Buy from Hold as its ASCO abstract increases the firm's confidence in the company's lung cancer strategy. The firm said Roche's lung study response rates were more compelling than originally thought possible and that the company is now well positioned to win the war in lung cancer.